Paul Sullivan
Associate Director, Business Development

About

Paul Sullivan is the Associate Director of Business Development at Noble®, a product development company with a focus in designing and manufacturing drug delivery training and patient on-boarding solutions.

Prior to Noble, Mr Sullivan worked at Informed Medical Communications, as a Director of Business Development and Client Service. His primary role was to train physician and nurse key opinion leaders on the skills of peer-to-peer influence and round-table moderating. In 2003, started his career in the pharmaceutical industry as a pharmaceutical sales representative with Procter & Gamble Pharmaceuticals and holds a Kinesiology degree with honors from the University of Western Ontario (Canada) and resides in Cincinnati, OH, US.

Contributions

PREFILLED SYRINGES

IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES

Paul Sullivan outlines how the growing trend towards patient self-injection, outside of the clinical setting, places an ever greater emphasis on quality training and onboarding. Mr Sullivan specifically explains how such training can help overcome the issue of patient needle fear or anxiety.

More contributions

PREFILLED SYRINGES

CONTINUOUS GROWTH & INNOVATION IN COMBINATION PRODUCT MARKET PRESENTS CHALLENGES & OPPORTUNITIES

Paul Sullivan describes how smart, error-detecting training devices that are true to the form and function of the actual device deliver the most promising impact on adherence and compliance for patient self-injection.

PULMONARY

PATIENT PREFERENCE: DEVICE TRAINING & EDUCATION TOOLS

Paul Sullivan and Craig Baker point out that most patients with asthma do not use their inhaler properly, and review evidence from a trial of five different methods designed to improve inhaler use. They conclude that training devices could be effective tools to increase patient confidence and reduce anxiety.

PULMONARY

PATIENT PREFERENCE IN RESPIRATORY DEVICE TRAINING & EDUCATIONAL TOOLS

Paul Sullivan and Craig Baker provide data from recent patient studies to emphasise the importance of training devices in improving adherence to, and compliance with, inhaled therapeutics.